Global Factor IX Drug Pipeline Landscape Report 2024: Therapeutic Assessment by Stage, Route of Administration, and Molecule Type
February 29, 2024 10:52 ET
|
Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Factor IX - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
Global Blood Plasma Derivatives Market Report 2022: Featuring Bayer, Takeda Pharmaceutical, Grifols, Biotest & More
December 02, 2022 04:53 ET
|
Research and Markets
Dublin, Dec. 02, 2022 (GLOBE NEWSWIRE) -- The "Global Blood Plasma Derivatives Market Size, Share & Industry Trends Analysis Report by Application, End-user, Type (Immunoglobulin, Albumin,...
Global Hemophilia Treatment Market Report to 2031: Players Include Bayer, Pfizer, F. Hoffmann-La Roche and CSL
November 11, 2022 04:50 ET
|
Research and Markets
Dublin, Nov. 11, 2022 (GLOBE NEWSWIRE) -- The "Hemophilia Treatment Market By Type, By Drug Therapy: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ...
Insights on the Hemophilia Global Market to 2026 - Increased Focus on Prophylactic Treatment Presents Opportunities
March 03, 2022 04:38 ET
|
Research and Markets
Dublin, March 03, 2022 (GLOBE NEWSWIRE) -- The "Global Hemophilia Market: Size, Trends & Forecast with Impact of COVID-19 (2022-2026)" report has been added to ResearchAndMarkets.com's offering....
Global Human Coagulation Factor IX Market Insights (2021 to 2025) - Key Analysis and Forecasts
August 31, 2021 05:43 ET
|
Research and Markets
Dublin, Aug. 31, 2021 (GLOBE NEWSWIRE) -- The "Human Coagulation Factor IX Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product...